Oncology MRI

>

Latest News

Assessing Post-Treatment MRI for Predicting Neoadjuvant Chemoimmunotherapy Response for Triple-Negative Breast Cancer
Assessing Post-Treatment MRI for Predicting Neoadjuvant Chemoimmunotherapy Response for Triple-Negative Breast Cancer

July 3rd 2025

In external testing, a model combining radiological complete response on breast MRI, nodal status and Ki-67 proliferation index yielded an 88 percent AUC for predicting pathologic complete response to neoadjuvant chemoimmunotherapy for patients with triple-negative breast cancer, according to new research.

FDA Clears SmartSpeed Precise MRI Software from Philips
FDA Clears SmartSpeed Precise MRI Software from Philips

July 2nd 2025

FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers

June 26th 2025

Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?

June 17th 2025

Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI

June 16th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.